Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00316134 · ClinicalTrials.gov registry record
Multiple Biomarkers in Undiagnosed Pleural Effusion
A clinical trial, sponsored by Fujirebio Diagnostics.
- Terminated
- Registry status
- 200
- Enrollment target
NCT00316134 is a clinical trial that was terminated before completion, run by Fujirebio Diagnostics. The registered enrollment target is 200 participants.
The verdict
NCT00316134 was terminated before completion, sponsored by Fujirebio Diagnostics.
- TERMINATED
- Registry status
- 200 participants
- Enrollment target
Study Summary
The purpose of this clinical trial is to evaluate the ability of various biomarkers measured in serum and/or pleural fluids to estimate the risk of finding cancer in patients with undiagnosed pleural effusions. An algorithm for prediction of the risk of finding cancer in the patient using an optimal combination of markers will be developed, and patients will be categorized as having a low, moderate, or high risk of finding cancer that might be used to more effectively triage patients.
Interventions
- PROCEDURE Procedure/Surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2006-03 |
| Est. Completion | 2008-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00316134
The ClinicalTrials.gov registry entry for NCT00316134 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fujirebio Diagnostics, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Procedure/Surgery is the first listed.
NCT00316134 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00316134 about?
NCT00316134 is a clinical study titled "Multiple Biomarkers in Undiagnosed Pleural Effusion". The purpose of this clinical trial is to evaluate the ability of various biomarkers measured in serum and/or pleural fluids to estimate the risk of finding cancer in patients with undiagnosed pleural effusions. An algorithm for prediction of the risk of finding cancer in the patient using an optimal...
What is the current status of trial NCT00316134?
This trial is currently terminated. The enrollment target is 200 participants. The study started on 2006-03. Estimated completion is 2008-02.
What interventions are being tested in trial NCT00316134?
The interventions under investigation include: Procedure/Surgery (PROCEDURE).
Who is sponsoring clinical trial NCT00316134?
This trial is sponsored by Fujirebio Diagnostics, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.